174 related articles for article (PubMed ID: 20006463)
1. Preparation and pharmaceutical evaluation of new sustained-release capsule including starch-sponge matrix (SSM).
Shibata N; Nishumura A; Naruhashi K; Nakao Y; Miura R
Biomed Pharmacother; 2010 May; 64(5):352-8. PubMed ID: 20006463
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
3. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.
Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S
Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370
[TBL] [Abstract][Full Text] [Related]
4. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
Brouillet F; Bataille B; Cartilier L
Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
[TBL] [Abstract][Full Text] [Related]
5. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic erosion of bioartificial membranes to control drug delivery.
Coluccio ML; Ciardelli G; Bertoni F; Silvestri D; Cristallini C; Giusti P; Barbani N
Macromol Biosci; 2006 Jun; 6(6):403-11. PubMed ID: 16775815
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting zero-order release kinetics of porous gelatin capsules.
Chen GL; Hao WH
Drug Dev Ind Pharm; 1998 Jun; 24(6):557-62. PubMed ID: 9876623
[TBL] [Abstract][Full Text] [Related]
8. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
[TBL] [Abstract][Full Text] [Related]
9. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
10. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
11. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process.
Brouillet F; Baylac G; Cartilier L; Bataille B
Drug Dev Ind Pharm; 2010 Jul; 36(7):795-805. PubMed ID: 20136492
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
13. Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase.
Tuovinen L; Peltonen S; Liikola M; Hotakainen M; Lahtela-Kakkonen M; Poso A; Järvinen K
Biomaterials; 2004 Aug; 25(18):4355-62. PubMed ID: 15046926
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluation.
Zhang JX; Li XJ; Qiu LY; Li XH; Yan MQ; Yi Jin ; Zhu KJ
J Control Release; 2006 Dec; 116(3):322-9. PubMed ID: 17109985
[TBL] [Abstract][Full Text] [Related]
15. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
M K; Sistla R; Shastri NR
Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
Lu B; Wen R; Yang H; He Y
Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
[TBL] [Abstract][Full Text] [Related]
17. Drug release behaviour from methyl methacrylate-starch matrix tablets: effect of polymer moisture content.
Bravo-Osuna I; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2008 May; 69(1):285-93. PubMed ID: 17997292
[TBL] [Abstract][Full Text] [Related]
18. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
[TBL] [Abstract][Full Text] [Related]
19. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
[TBL] [Abstract][Full Text] [Related]
20. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
